Bevacizumab Plus mFOLFOXIRI as First-line Treatment for Patients With Unresectable Metastatic Colorectal Cancer
Clinical trial NCT04230187 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04230187
- Sponsor
- Yanhong Deng
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2026-09-01
- Enrollment
- 528
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.